Please analyze the epidemiologic transition that traces the long-term AD mortality rate decline in terms of changes in the causes of death, along with risk factors, and the magnitude of the problem that includes the prevalence, incidence, and mortality of AD patients. Provide specific examples to support your response.
Additionally, from the e-Activity below, I need assistance suggesting possible changes in how the detection and treatment of Alzheimer's disease could be addressed in the U.S. Please explain the rationale.© BrainMass Inc. brainmass.com June 4, 2020, 3:43 am ad1c9bdddf
In 2011, Alzheimer's Disease was the 6th leading cause of death in the United States, ahead of Diabetes (Hoyert & XU, 2012). The effects of the disease lead to conditions that shorten the lifespan and health challenges faced during the final stages of life. Bronchopneumonia is the leading cause of death among people with AD. The death rate for people age 75 to 84 with AD is 9 times higher than the general population (Alzheimer's Association, 2012). Though length of survival with AD is increasing, due to development of medications that slow cognitive dysfunction, AD mortality increased
65% from 2000 to 2008.
AD diagnosis increases expectations of health problems that would not be present in an otherwise healthy individual. Late stage symptoms include inability to speak, walk, and swallow. Inability to walk and to absorb nutrients may increase the risk of infection, particularly related to the respiratory system. Though bronchopneumonia is the leading cause of death among those suffering from AD, other potentially serious illnesses include urinary tract infection and injury. UTIs can go undetected in people with AD living at home and can lead to serious kidney infection if not treated
promptly. Injury and risk of injury are due to disorientation and lack of ability to sleep, often causing those with AD to wander in the middle of the ...
The magnitude of Alzheimer's diseases are examined. The expert determines how the use of the internet to research the current impact to the United States health care system from the number of people suffering from Alzheimer's diseases.